Although CTNNB1 mutations are more common in adenomas (12.5%) than invasive cancer (1.4%), they are found in the preliminary stages of CRC pathogenesis and plausibly substitute APC mutations in cancer onset and progression [54,55,56]. This evidence concerns the gene APC and cancer.